Celldex Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $301k | 12k | 25.87 |
| 2024-09-30 | $2.9M | 87k | 33.99 |
| 2024-03-31 | $2.7M | 65k | 41.97 |
| 2023-12-31 | $957k | 24k | 39.66 |
| 2023-09-30 | $755k | 27k | 27.52 |
| 2022-03-31 | $2.1M | 61k | 34.06 |
| 2021-12-31 | $284k | 7.4k | 38.58 |